Cargando…

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML

Chromosomal translocations involving the NUP98 locus are among the most prevalent rearrangements in pediatric acute myeloid leukemia (AML). AML with NUP98 fusions is characterized by high expression of HOXA and MEIS1 genes and is associated with poor clinical outcome. NUP98 fusion proteins are recru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasouli, Milad, Blair, Helen, Troester, Selina, Szoltysek, Katarzyna, Cameron, Rachel, Ashtiani, Minoo, Krippner-Heidenreich, Anja, Grebien, Florian, McGeehan, Gerard, Zwaan, C. Michel, Heidenreich, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378738/ https://www.ncbi.nlm.nih.gov/pubmed/37520776 http://dx.doi.org/10.1097/HS9.0000000000000935

Ejemplares similares

The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML
por: Heikamp, Emily B., et al.
Publicado: (2022)

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
por: Fiskus, Warren, et al.
Publicado: (2022)

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2023)

SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation
por: Jevtic, Zivojin, et al.
Publicado: (2022)

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2022)

Molecular pathogenesis of disease progression in MLL-rearranged AML
por: Kotani, Shinichi, et al.
Publicado: (2018)

Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
por: Brzezinka, Krzysztof, et al.
Publicado: (2020)

Development of an orally bioavailable selective inhibitor of the menin-MLL
por: Zhong, Hai-Jing, et al.
Publicado: (2022)

Initiation of MLL-rearranged AML is dependent on C/EBPα
por: Ohlsson, Ewa, et al.
Publicado: (2014)

IKAROS and MENIN Coordinate Therapeutically Actionable Leukaemogenic Gene Expression in MLL-r Acute Myeloid Leukaemia
por: Aubrey, Brandon J., et al.
Publicado: (2022)

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1
por: Numata, Masashi, et al.
Publicado: (2023)

P444: SINGLE CELL RNASEQ UNCOVERING THE ROLE OF A LEUKEMIC DRIVER GENE FUSION CBFΒ::MYH11 IN THE LEUKEMIC–NICHE SIGNALING
por: Derevyanko, Polina, et al.
Publicado: (2023)

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition
por: Soto-Feliciano, Yadira M., et al.
Publicado: (2023)

DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
por: Liu, Wei, et al.
Publicado: (2014)

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
por: Ye, Jing, et al.
Publicado: (2019)

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
por: Issa, Ghayas C., et al.
Publicado: (2023)

P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
por: Wijnen, Noa, et al.
Publicado: (2023)

ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
por: Golovine, Konstantin, et al.
Publicado: (2023)

S125: NON-GENETIC RESISTANCE TO MENIN INHIBITION IN AML IS REVERSIBLE BY PERTURBATION OF KAT6A
por: Perner, Florian, et al.
Publicado: (2023)

Uncleavable Nup98–Nup96 is functional in the fission yeast Schizosaccharomyces pombe
por: Asakawa, Haruhiko, et al.
Publicado: (2015)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin
por: Svoboda, Laurie K., et al.
Publicado: (2016)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2020)

Menin is necessary for long term maintenance of meningioma-1 driven leukemia
por: Libbrecht, Clara, et al.
Publicado: (2021)

Dynamic Association of NUP98 with the Human Genome
por: Liang, Yun, et al.
Publicado: (2013)

Nup98-Homeodomain Fusions Interact with Endogenous Nup98 during Interphase and Localize to Kinetochores and Chromosome Arms during Mitosis
por: Xu, Songli, et al.
Publicado: (2010)

Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia
por: Issa, Hasan, et al.
Publicado: (2023)

NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid Leukemia
por: Barresi, Vincenza, et al.
Publicado: (2021)

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
por: Negri, A., et al.
Publicado: (2023)

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity
por: Dreijerink, Koen M. A., et al.
Publicado: (2022)

Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice
por: Kundu, Subhadip, et al.
Publicado: (2019)

Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients
por: Shah, Arunim, et al.
Publicado: (2022)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement
por: Gallego Hernanz, Maria Pilar, et al.
Publicado: (2019)

NUP98 Rearrangement in Acute Myelomonocytic Leukemia With t(11;19)(p15;p12): The First Case Report Worldwide
por: Lim, Hyeon-Ho, et al.
Publicado: (2017)

First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review
por: Fu, Weijia, et al.
Publicado: (2021)

Phosphorylation but Not Oligomerization Drives the Accumulation of Tau with Nucleoporin Nup98
por: Diez, Lisa, et al.
Publicado: (2022)

Nup98-dependent transcriptional memory is established independently of transcription
por: Pascual-Garcia, Pau, et al.
Publicado: (2022)

LBODP106 Multi-omics Analyses Of MEN1 Missense Mutations Identify Disruption Of Menin-MLL And Menin-JunD Interactions As Critical Requirements For Molecular Pathogenicity
por: Dreijerink, Koen Marie Anton, et al.
Publicado: (2022)

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax
por: Rausch, Johanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bokpjr6k54g4mellvtklflagff